Intra-Cellular Therapies
ITCI
#1827
Rank
โ‚ฌ8.53 B
Marketcap
80,51ย โ‚ฌ
Share price
-0.82%
Change (1 day)
35.00%
Change (1 year)

Market capitalization of Intra-Cellular Therapies (ITCI)

Market cap: โ‚ฌ8.53 Billion

As of December 2024 Intra-Cellular Therapies has a market cap of โ‚ฌ8.53 Billion. This makes Intra-Cellular Therapies the world's 1827th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Intra-Cellular Therapies from 2013 to 2024

End of year Market Cap

Year Marketcap Change
2024โ‚ฌ8.53 B36.9%
2023โ‚ฌ6.23 B33.45%
2022โ‚ฌ4.67 B24.1%
2021โ‚ฌ3.76 B80.98%
2020โ‚ฌ2.08 B22.36%
2019โ‚ฌ1.70 B211.05%
2018โ‚ฌ0.54 B-17.02%
2017โ‚ฌ0.65 B6.11%
2016โ‚ฌ0.62 B-70.76%
2015โ‚ฌ2.12 B395.93%
2014โ‚ฌ0.42 B33.4%
2013โ‚ฌ0.32 B

End of Day market cap according to different sources

On Dec 20th, 2024 the market cap of Intra-Cellular Therapies was reported to be:

โ‚ฌ8.53 Billion
by Nasdaq info icon info icon
โ‚ฌ8.53 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
โ‚ฌ0.10 B-98.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ25.16 M-99.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.62 B-80.91%๐Ÿ‡บ๐Ÿ‡ธ USA